| Literature DB >> 7891672 |
A Sigel1, J A Douglas, M Eghbali-Webb.
Abstract
Transforming Growth Factor-beta 1 (TGF-beta 1) is expressed in the heart by muscle and non-muscle cardiac cells. In vitro, cardiac myocytes and non-muscle cells including cardiac fibroblasts and endothelial cells respond to regulatory effects of TGF-beta 1. Expression of TGF-beta 1 in the heart is subject to regulation by hemodynamic stimuli. Increased expression of mRNA transcripts for TGF-beta 1 has been reported in several models of cardiac hypertrophy. The objective of this study was to determine the effect of TGF-beta 1 in the myocardium. TGF-beta 1 was injected intravenously. Expression of mRNA transcripts for functional and structural proteins was determined by Northern hybridization analysis. DNA synthesis was determined by measurement of 3H-thymidine incorporation into ventricular DNA. The results showed differential regulation of mRNAs for myocyte- and non-myocyte-specific proteins in the heart of TGF-beta 1 treated rats. Moderate but statistically significant decrease in DNA synthesis was observed in the heart of TGF-beta 1 treated rats (37.5%, P < 0.025). Together, these data point to a physiological role for TGF-beta 1 in the heart. They further suggest that similar to its diverse in vitro cell-specific regulatory effects, TGF-beta 1 may have multicellular targets in the heart. Effect of TGF-beta 1 alone or combined with those of other cytokines/hormones that come into play, as the result of its administration, may be responsible for altered gene expression and DNA synthesis in the myocardium.(ABSTRACT TRUNCATED AT 250 WORDS)Entities:
Mesh:
Substances:
Year: 1994 PMID: 7891672 DOI: 10.1007/bf00926178
Source DB: PubMed Journal: Mol Cell Biochem ISSN: 0300-8177 Impact factor: 3.396